Cargando...
Crizotinib-induced pancreatic pseudocyst: a novel adverse event
Crizotinib is a tyrosine kinase inhibitor that demonstrates a dramatic tumour response in patients with advanced non-small cell lung cancers harbouring anaplastic lymphoma kinase (ALK) rearrangement. The pancreatic cyst has never been reported in patients who received crizotinib, whereas crizotinib-...
Gardado en:
| Publicado en: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567757/ https://ncbi.nlm.nih.gov/pubmed/26351314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-211556 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|